Advanced Diagnostic Breast Cancer Imaging: Variation and Patterns of Care in Washington State

Gold, Laura S.; Buist, Diana S.M.; Loggers, Elizabeth T.; Etzioni, Ruth; Kessler, Larry G.; Ramsey, Scott D.; Sullivan, Sean D.

doi:10.1200/jop.2012.000796

Cited by 19 publications

(12 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Similar to another study, performed in the United States, 23 we have shown that a range of patient, tumour and treatment characteristics are associated with increased imaging use, which may be useful in improving adherence. For example, certain adverse tumour characteristics such as stage, involvement of the axillary lymph nodes, lymphovascular invasion, negative HER2 status and tumour grade were all associated with increased utilization of imaging.…”

Section: Discussionsupporting

confidence: 63%

Imaging for distant metastases in women with early-stage breast cancer: a population-based cohort study

Simos

Catley

Walraven

et al. 2015

CMAJ

View full text Add to dashboard Cite

Interpretation: Despite recommendations from multiple international guidelines, most Ontario women with early-stage breast cancer underwent imaging to detect distant metastases. Inappropriate imaging in asymptomatic patients with early-stage disease is costly and may lead to harm. The use of population datasets will allow investigators to evaluate whether or not strategies to implement practice guidelines lead to meaningful and sustained change in physician practice. AbstractCMAJ Podcasts: editor's summary at soundcloud

show abstract

Section: Discussionsupporting

confidence: 63%

Imaging for distant metastases in women with early-stage breast cancer: a population-based cohort study

Simos

Catley

Walraven

et al. 2015

CMAJ

View full text Add to dashboard Cite

show abstract

“…We linked health plan enrollment and utilization files from three commercial health plans (Regence Blue Shield, Premera Blue Cross, and Uniform Medical Plan), one mixed-model health delivery system (Group Health Cooperative) and two publically funded health care programs (Medicaid and Medicare) with the western Washington Surveillance Epidemiology and End Results registry [ 25 ]. The linkage identified all adult (age: 18 years or older) females diagnosed with an incident invasive breast carcinoma between 2002 and 2008.…”

Section: Methodsmentioning

confidence: 99%

Advanced Imaging and Receipt of Guideline Concordant Care in Women with Early Stage Breast Cancer

Loggers

Buist

Gold

et al. 2016

International Journal of Breast Cancer

Self Cite

View full text Add to dashboard Cite

Objective. It is unknown whether advanced imaging (AI) is associated with higher quality breast cancer (BC) care. Materials and Methods. Claims and Surveillance Epidemiology and End Results data were linked for women diagnosed with incident stage I-III BC between 2002 and 2008 in western Washington State. We examined receipt of preoperative breast magnetic resonance imaging (MRI) or AI (defined as computed tomography [CT]/positron emission tomography [PET]/PET/CT) versus mammogram and/or ultrasound (M-US) alone and receipt of guideline concordant care (GCC) using multivariable logistic regression. Results. Of 5247 women, 67% received M-US, 23% MRI, 8% CT, and 3% PET/PET-CT. In 2002, 5% received MRI and 5% AI compared to 45% and 12%, respectively, in 2008. 79% received GCC, but GCC declined over time and was associated with younger age, urban residence, less comorbidity, shorter time from diagnosis to surgery, and earlier year of diagnosis. Breast MRI was associated with GCC for lumpectomy plus radiation therapy (RT) (OR 1.55, 95% CI 1.08–2.26, and p = 0.02) and AI was associated with GCC for adjuvant chemotherapy for estrogen-receptor positive (ER+) BC (OR 1.74, 95% CI 1.17–2.59, and p = 0.01). Conclusion. GCC was associated with prior receipt of breast MRI and AI for lumpectomy plus RT and adjuvant chemotherapy for ER+ BC, respectively.

show abstract

“…In contrast to the well-established guidelines for MRI screening in patients with an inherited predisposition to breast cancer, 9 to our knowledge, there are no guidelines for MRI use in patients with newly diagnosed breast cancer; nevertheless, a report from Western Washington State's Surveillance, Epidemiology, and End Results (SEER) registry demonstrated that 27% of 9196 women with breast cancer underwent MRI for staging or treatment planning between 2002 and 2009, 10 and by 2009, 46% of women underwent perioperative breast MRI. MRI use varied significantly based on age, with 45% of women aged 18 years to 40 years undergoing an MRI compared with 10% of those aged 81 years (P < .001).…”

Section: Current Mri Usementioning

confidence: 99%

Magnetic resonance imaging in patients with newly diagnosed breast cancer: A review of the literature

Pilewskie

King

2014

Cancer

View full text Add to dashboard Cite

The use of magnetic resonance imaging (MRI) in patients with newly diagnosed breast cancer remains controversial. Here we review the current use of breast MRI and the impact of MRI on short-term surgical outcomes and rates of local recurrence. In addition, we address the use of MRI in specific patient populations, such as those with ductal carcinoma in situ, invasive lobular carcinoma, and occult primary breast cancer, and discuss the potential role of MRI for assessing response to neoadjuvant chemotherapy. Although MRI has improved sensitivity compared with conventional imaging, this has not translated into improved short-term surgical outcomes or long-term patient benefit, such as improved local control or survival, in any patient population. MRI is an important diagnostic test in the evaluation of patients presenting with occult primary breast cancer and has shown promise in monitoring response to neoadjuvant chemotherapy; however, the data do not support the routine use of perioperative MRI in patients with newly diagnosed breast cancer. Cancer 2014;120:2080-9. V C 2014 American Cancer Society.KEYWORDS: magnetic resonance imaging (MRI), breast cancer, breast-conserving surgery, local recurrence. INTRODUCTIONThe use of magnetic resonance imaging (MRI) in patients with newly diagnosed breast cancer requires balancing the positive and negative aspects of additional imaging and, as evidenced by the growing number of editorials and reviews arguing for or against the routine use of MRI, 1-8 remains an area of significant controversy. This debate has been fueled by inconsistent data largely comprised of small, single-institution retrospective studies, although 2 randomized controlled trials (RCTs) and several meta-analyses have provided more robust data evaluating MRI in the perioperative setting. The "pros" of perioperative MRI include improved sensitivity compared with conventional imaging and therefore increased identification of multifocal, multicentric, or contralateral disease. With improved sensitivity comes a theoretical improvement in short-term surgical management and/or long-term outcomes. The "cons" of perioperative MRI include the high falsepositive rate, potential treatment delays, increased mastectomy rates and cost, and, some argue, overdiagnosis and overtreatment of MRI-only detected disease. Here we review the relevant data regarding MRI use in patients with newly diagnosed breast cancer, examining both the short-term and long-term outcomes, MRI use in populations of women with ductal carcinoma in situ (DCIS) and invasive lobular carcinoma (ILC), MRI's role in patients presenting with occult primary breast cancer, and MRI's ability to evaluate neoadjuvant chemotherapy (NAC) response.

show abstract

Advanced Diagnostic Breast Cancer Imaging: Variation and Patterns of Care in Washington State

Cited by 19 publications

References 34 publications

Imaging for distant metastases in women with early-stage breast cancer: a population-based cohort study

Imaging for distant metastases in women with early-stage breast cancer: a population-based cohort study

Advanced Imaging and Receipt of Guideline Concordant Care in Women with Early Stage Breast Cancer

Magnetic resonance imaging in patients with newly diagnosed breast cancer: A review of the literature

Contact Info

Product

Resources

About